NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $38,554,000 | -7.4% | 1,083,598 | -12.5% | 3.03% | -8.1% |
| Q1 2019 | $41,613,000 | +11.6% | 1,238,489 | +9.2% | 3.29% | +6.0% |
| Q4 2018 | $37,288,000 | -46.1% | 1,134,414 | 0.0% | 3.11% | -22.3% |
| Q3 2018 | $69,154,000 | +24.8% | 1,134,414 | 0.0% | 4.00% | +33.3% |
| Q2 2018 | $55,393,000 | -22.0% | 1,134,414 | +69.7% | 3.00% | -30.3% |
| Q1 2018 | $71,034,000 | -13.0% | 668,492 | -51.1% | 4.31% | -20.1% |
| Q4 2017 | $81,647,000 | +49.6% | 1,367,171 | -39.9% | 5.39% | +64.9% |
| Q3 2017 | $54,592,000 | -0.7% | 2,274,661 | -19.1% | 3.27% | +4.2% |
| Q2 2017 | $54,957,000 | -20.3% | 2,811,092 | -4.3% | 3.14% | -20.3% |
| Q1 2017 | $68,937,000 | +42.4% | 2,937,255 | -25.5% | 3.93% | +16.9% |
| Q4 2016 | $48,401,000 | -0.5% | 3,944,692 | +39.3% | 3.36% | +2.6% |
| Q3 2016 | $48,665,000 | -5.0% | 2,832,636 | -21.3% | 3.28% | -0.8% |
| Q2 2016 | $51,207,000 | +5.9% | 3,598,554 | +2.3% | 3.31% | -1.0% |
| Q1 2016 | $48,359,000 | +83.5% | 3,517,011 | +124.9% | 3.34% | +283.7% |
| Q4 2015 | $26,351,000 | – | 1,563,862 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |